ANG

ANG Lifesciences India Ltd.

BSE: 540694

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

26.82+1.3 (+4.97%)

25 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

35.02

P/E (TTM)

P/B

0.66

P/S (TTM)

0.42

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-18.97

ROCE (TTM)

-4.02

ROA (TTM)

-5.06

Avg 3Y ROE

-16.39

Earnings 3Y CAGR

-98.51

Sales 3Y CAGR

-25.56

Sales 5Y CAGR

-9.66

Debt/Equity

1.50

Consensus TP

Strong Buy %

Promoter Holding

70.60

Pledged %

44.88

Stock Analysis

Fundamental analysis overview of ANG Lifesciences India Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -38.04% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low but stable ROE

The company reported low ROE of -18.97% for 12-month ended 30 Jun 2026 and ROE declined marginally by -126 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of -9.8% for 12-month ended 30 Jun 2026 and operating margin declined by -317 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -15.6% for 12-month ended 30 Jun 2026 and the growth was 26.19 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value -15.6

-99.6111701.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -17.34% for 12-month ended 30 Jun 2026 and the growth was 24.54 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Reasonable Debt to Equity, and has been stable

The company has reasonable Debt to Equity of 1.5 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.2 in the last 1 year

What is Debt to Equity?

Financial Snapshot

See detailed analysis

Multi-year trends for ANG Lifesciences India Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

ANG Lifesciences India Ltd. Shareholding Pattern

Quarterly breakdown of ANG Lifesciences India Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2018	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	71.01	71.01	71.01	71.01	71.01	71.01	71.07	71.09	71.14	71.15	71.15	71.15	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60
Indian Promoter	71.01	71.01	71.01	71.01	71.01	71.01	71.07	71.09	71.14	71.15	71.15	71.15	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60	70.60
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	28.99	28.99	28.99	28.99	28.99	28.99	28.93	28.91	28.86	28.85	28.85	28.85	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40	29.40
Bodies Corporate	14.20	10.22	10.46	8.69	8.46	6.24	-	-	-	0.79	0.99	1.29	1.06	1.05	0.93	0.98	0.76	0.73	0.66	0.22	0.21	0.21	0.22	0.22	0.22
Others (incl. Retail) No. of shareholders	14.79 259	18.77 304	18.53 330	20.30 326	20.53 350	22.75 321	28.93 321	28.91 2,520	28.86 4,257	28.06 5,182	27.86 6,903	27.56 6,910	28.34 7,128	28.35 7,270	28.47 7,024	28.42 6,888	28.64 6,839	28.67 6,604	28.74 6,442	29.18 6,496	29.19 6,489	29.19 6,381	29.18 6,252	29.18 6,063	29.18 5,930

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in ANG Lifesciences India Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Rajesh Gupta Promoter Group	August-2021	Market Purchase (Acquisition) 12th Aug 2021	70.81 %	₹ 440.00	3.20 k	₹ 14.08 lac

Corporate Actions

History of ANG Lifesciences India Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 4 existing shares
Ex-date: 13th Jul 2022Announced on: 30th May 2022
Dividend₹ 1/share
Record date: 4th Nov 2021Ex-date: 2nd Nov 2021
Announced on: 25th Oct 2021
Bonus1 new shares for 1 existing shares
Ex-date: 22nd Sep 2021Announced on: 6th Aug 2021

Company Profile

Overview of ANG Lifesciences India Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and print...

Key personnel

Ms. Harshita Aggarwal

Compliance Officer, Company Secretary

Mr. Rajesh GuptaD

Managing Director, Director

Mr. Rohit MittalD

Additional Non-Executive Non-Independent Director

Mrs. ChetnaD

Additional Non-Executive Independent Director

Mr. Sukhpal SinghD

Non-Executive Independent Director

Incorporated on

14 Jun 2006

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

08 Sep 2017

Free Float

38,38,750

Website

https://anglifesciences.com/

Phone no.

+911835070118

Address

DARBARA COMPLEX, SCO 113 FIRST FLOOR, DISTRICT SHOPPING CENTRE, B BLOCK , RANJITAVENUE, , 143001, India

Frequently Asked Questions

What is the current share price of ANG Lifesciences India Ltd.?

The current share price of ANG Lifesciences India Ltd. is ₹ 26.82 as of 25 Aug 2026.

What is the market capitalisation of ANG Lifesciences India Ltd.?

The market capitalisation of ANG Lifesciences India Ltd. stands at ₹ 35.02 Cr.

What is the PE ratio of ANG Lifesciences India Ltd.?

The Price-to-Earnings (PE) ratio of ANG Lifesciences India Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of ANG Lifesciences India Ltd.?

ANG Lifesciences India Ltd. has a Return on Equity (ROE) of -18.97% and a Return on Capital Employed (ROCE) of -4.02% as per the latest financial reports.

What is the 52-week high and low of ANG Lifesciences India Ltd.?

The 52-week high of ANG Lifesciences India Ltd. is - and the 52-week low is -.

What is the dividend yield of ANG Lifesciences India Ltd.?

The dividend yield of ANG Lifesciences India Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in ANG Lifesciences India Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 29.18% of ANG Lifesciences India Ltd. shares.

What sector does ANG Lifesciences India Ltd. belong to?

ANG Lifesciences India Ltd. operates in the Healthcare sector.

What is the beta of ANG Lifesciences India Ltd.?

The beta of ANG Lifesciences India Ltd. is 0.46, indicating its price volatility relative to the broader market. Over the past 1 year, ANG Lifesciences India Ltd. has delivered an absolute return of -9.91%.

What is the RSI of ANG Lifesciences India Ltd.?

The 14-day Relative Strength Index (RSI) of ANG Lifesciences India Ltd. is 37.25, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

ANG Lifesciences India Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

ANG Lifesciences India Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile